LICQual Level 6 Diploma in Pharmacoeconomics
Healthcare systems worldwide face the challenge of balancing innovation with affordability. New therapies, biologics, and advanced treatments promise better outcomes, but they also come with rising costs that strain budgets and limit access. This is where pharmacoeconomics becomes essential. By evaluating the economic impact of medicines and healthcare interventions, pharmacoeconomics ensures that resources are used wisely, patients receive value‑based care, and decision‑makers can prioritize treatments that deliver the greatest benefit.
The LICQual Level 6 Diploma in Pharmacoeconomics (D Pharmacoeconomics) highlights the importance of this discipline in shaping sustainable healthcare. Pharmacoeconomics is not simply about cost—it is about measuring effectiveness, improving efficiency, and ensuring equity in healthcare delivery. As global health systems evolve, professionals trained in this area are vital for guiding policy, supporting reimbursement decisions, and advancing patient access to essential medicines. For learners, engaging with this subject is more than academic—it is an opportunity to influence healthcare policy, strengthen pharmaceutical practice, and play a pivotal role in creating systems that balance innovation with affordability.
Program Outline
The LICQual Level 6 Diploma is a structured qualification designed to provide learners with advanced knowledge of healthcare economics and pharmaceutical decision‑making. Comprising 6 specialized units and worth 120 credits, the program introduces learners to areas such as cost‑effectiveness analysis, health technology assessment, compliance frameworks, resource allocation, ethical considerations, and international healthcare policies.
This section explains how the course equips learners with the ability to apply evidence‑based approaches, evaluate healthcare interventions, and align with global standards effectively. It highlights the type of learners the program is aimed at, the skills they will gain, and the career pathways available upon completion. Readers will also discover how this internationally recognized qualification opens opportunities in hospitals, pharmaceutical companies, government agencies, and research institutions, making it a valuable credential for anyone aspiring to build a career in healthcare economics and pharmaceutical policy.
Unit Structure
| Qualification | Unit Title | Credits | GLH |
| LICQ2201192-1 | Introduction to Pharmacoeconomics | 20 | 80 |
| LICQ2201192-2 | Health Technology Assessment (HTA) | 20 | 80 |
| LICQ2201192-3 | Cost Analysis and Budget Impact Modelling | 20 | 80 |
| LICQ2201192-4 | Pharmacoeconomics Data Analysis and Research Methods | 20 | 80 |
| LICQ2201192-5 | Market Access and Healthcare Policy | 20 | 80 |
| LICQ2201192-6 | Advanced Pharmacoeconomics Project | 20 | 80 |
Who Can Benefit
The LICQual Level 6 Diploma is tailored for individuals seeking to advance their expertise in healthcare economics and pharmaceutical policy. It is especially valuable for those aiming to tackle challenges such as managing costs, ensuring fair access to medicines, and applying evidence‑based strategies for resource allocation. This qualification enables learners to deepen their knowledge, enhance career prospects, and prepare for roles where economic evaluation and policy decisions are critical to improving healthcare systems.
Ideal Learners
- Students aspiring to enter pharmaceutical sciences with a focus on healthcare economics.
- Entry‑level professionals seeking structured training in pharmacoeconomics.
- Pharmacy assistants wanting to expand knowledge of cost‑effectiveness analysis.
- Community pharmacy staff preparing for responsibilities in healthcare policy.
- Hospital pharmacy technicians aiming to strengthen skills in pharmacoeconomics.
- Healthcare professionals transitioning into pharmacoeconomics roles.
- Career changers interested in pharmaceutical economics and healthcare management.
- Ambitious learners who want to develop practical skills for pharmacoeconomics careers.
What You’ll Be Able to Do
Unit 1: Introduction to Pharmacoeconomics
By the end of this unit, learners will be able to:
- Explain the principles and concepts of pharmacoeconomics in healthcare decision-making
- Analyse cost-effectiveness, cost-utility, and cost-benefit frameworks
- Evaluate the economic impact of pharmaceutical interventions on healthcare systems
- Apply pharmacoeconomic reasoning to real-world clinical and policy scenarios
Unit 2: Health Technology Assessment (HTA)
By the end of this unit, learners will be able to:
- Demonstrate understanding of HTA frameworks and methodologies
- Critically assess clinical evidence, safety, and efficacy data for healthcare interventions
- Evaluate economic and social implications of introducing new healthcare technologies
- Apply HTA principles to inform policy, reimbursement, and resource allocation decisions
Unit 3: Cost Analysis and Budget Impact Modelling
By the end of this unit, learners will be able to:
- Perform cost-minimisation, cost-benefit, cost-effectiveness, and cost-utility analyses
- Develop and evaluate budget impact models for pharmaceutical interventions
- Analyse financial implications of healthcare interventions at organisational and system levels
- Interpret economic data to support strategic decision-making in healthcare
Unit 4: Pharmacoeconomics Data Analysis and Research Methods
By the end of this unit, learners will be able to:
- Design pharmacoeconomic studies and select appropriate research methodologies
- Analyse data using statistical and modelling techniques relevant to health economics
- Critically evaluate research findings for accuracy, reliability, and applicability
- Present pharmacoeconomic results effectively for academic, clinical, or policy audiences
Unit 5: Market Access and Healthcare Policy
By the end of this unit, learners will be able to:
- Explain the role of pharmacoeconomics in market access and healthcare policy development
- Analyse regulatory, pricing, and reimbursement frameworks affecting pharmaceutical products
- Evaluate strategies for successful market access and stakeholder engagement
- Apply pharmacoeconomic evidence to inform policy and commercial decisions
Unit 6: Advanced Pharmacoeconomics Project
By the end of this unit, learners will be able to:
- Plan and execute an independent research project in pharmacoeconomics
- Critically review scientific literature and economic data relevant to the project topic
- Apply analytical and modelling skills to evaluate healthcare interventions
- Present findings professionally, demonstrating advanced reasoning and decision-making capabilities
